Evangelia Papadimitriou

Professor

University of Patras

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Evangelia Papadimitriou is a faculty member at the University of Patras, Greece. Her research focuses on the regulation of pleiotrophin and its interaction with various receptors in the context of cancer therapy and bone metabolic disorders. She has contributed significantly to the understanding of hypoxia-induced cell migration and angiogenesis, as well as the pathophysiology of conditions such as osteogenesis imperfecta and neurofibromatosis type 1.

Articles (16)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Constantinos Mikelis

Associate Professor

University of Patras

GREECE

View details

Theodore Tselios

Professor

University of Patras

GREECE

View details

Emmanouil Athanasiadis

Assistant Professor

University of West Attica

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Evangelia Papadimitriou

Research Interests

Contact this professor

About

Articles (16)

Regulation of Pleiotrophin and PTPRZ1 Expression by Hypoxia to Restrict Hypoxia-Induced Cell Migration

Targeting the interaction of pleiotrophin and VEGFA165 with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesis

Unraveling the Link of Altered TGFβ Signaling with Scoliotic Vertebral Malformations in Osteogenesis Imperfecta: A Comprehensive Review

Bone mineral density, vitamin D and osseous metabolism indices in neurofibromatosis type 1: A systematic review and meta-analysis

Pleiotrophin Activates cMet- and mTORC1-Dependent Protein Synthesis through PTPRZ1—The Role of ανβ3 Integrin

Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and Diagnosis

Subchondral Bone Cyst Development in Osteoarthritis: From Pathophysiology to Bone Microarchitecture Changes and Clinical Implementations

Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c‐Met to up‐regulate angiogenesis and lung adenocarcinoma growth

Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish

Binding of pleiotrophin to cell surface nucleolin mediates prostate cancer cell adhesion to osteoblasts

Current Aspects on the Pathophysiology of Bone Metabolic Defects during Progression of Scoliosis in Neurofibromatosis Type 1

Doxycycline inhibits the progression of metastases in early-stage osteosarcoma by downregulating the expression of MMPs, VEGF and ezrin at primary sites

A Systematic Review on the Role of Adrenergic Receptors in Angiogenesis Regulation in Health and Disease

On the role of pleiotrophin and its receptors in development and angiogenesis

Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on α<sub>ν</sub>β<sub>3</sub> integrin expression

Regulation of Angiogenesis Discriminates Tissue Resident MSCs from Effective and Defective Osteogenic Environments

Collaborators (3)

Constantinos Mikelis

Theodore Tselios

Emmanouil Athanasiadis

Make your next move.